Atlas Trials

Supplemental Benefit of Angiotensin Receptor Blocker in Hypertensive Patients With Stable Heart Failure Using Olmesartan

Clinical trial NCT00417222 · COMPLETED

Trial details

NCT number
NCT00417222
Sponsor
Tohoku University
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Heart Failure
Start date
2006-11-01
Primary completion
2013-03-01
Enrollment
1145

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.